Obesity and cardiovascular disease: an ESC clinical consensus statement

Area of Science:

• Cardiology
• Public Health
• Metabolic Diseases

Background:

• Global obesity prevalence has doubled in four decades, affecting over a billion individuals.
• Obesity is a disease linked to chronic illnesses, reduced quality of life, and decreased life expectancy.
• Cardiovascular disease accounts for two-thirds of obesity-related excess mortality.

Purpose of the Study:

• To discuss the epidemiology and etiology of obesity.
• To explore the interplay between obesity, cardiovascular risk factors, and cardiac conditions.
• To provide guidance on the clinical management and weight loss strategies for patients with cardiac disease and obesity.

Main Methods:

• Review of current evidence on obesity and cardiovascular disease.
• Analysis of the impact of weight loss strategies on cardiometabolic risk and cardiac outcomes.
• Consensus statement development by the European Society of Cardiology.

Main Results:

• Obesity is underrecognized and sub-optimally managed compared to other cardiovascular risk factors.
• Comprehensive weight loss interventions are crucial for individuals with established obesity.
• Evidence-based practices for prevention and management are essential for primary and secondary cardiovascular disease prevention.

Conclusions:

• Obesity is a major, modifiable risk factor for cardiovascular disease.
• Integrated approaches are needed for population-based and personalized prevention and management of obesity.
• This statement aims to raise awareness and guide clinical practice for optimal patient outcomes.